SCHEMBL23920960

SCHEMBL23920960

CC(CSc1nc2c(=O)n3cc(-c4ccccc4)[nH]c3nc2n1CCO)PCSc1nc2c(=O)n3cc(-c4ccccc4)[nH]c3nc2n1CCO

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 8/20 0.44
ADORA1 P30542 3/20 0.44
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.34
TDP1 Q9NUW8 2/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
USP2 O75604 1/20 0.32
TSHR P16473 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
EPHB4 P54760 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920978 0.85 ADORA3 (0.52) ADORA3ADORA1TP53GAATDP1
SCHEMBL23920870 0.83 ADORA3 (0.52) ADORA3ADORA1TP53GAATDP1
SCHEMBL23921233 0.83 ADORA3 (0.51) ADORA3ADORA1TP53GAATDP1
SCHEMBL21396510 0.82 ADORA3 (0.46) ADORA3ADORA1TP53GAATDP1
SCHEMBL23921155 0.82 ADORA3 (0.46) ADORA3ADORA1TP53GAATDP1
SCHEMBL23921143 0.82 ADORA3 (0.46) ADORA3ADORA1TP53TDP1ALDH1A1
SCHEMBL23921219 0.81 ADORA3 (0.45) ADORA3ADORA1TP53ALDH1A1KDM4E
SCHEMBL21396458 0.80 ADORA3 (0.45) ADORA3ADORA1TP53GAATDP1
SCHEMBL23920929 0.78 ADORA3 (0.46) ADORA3ADORA1TP53GAATDP1
SCHEMBL21396522 0.78 RXFP1 (0.47) ADORA3ADORA1TP53GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES MIRECA MEDICINES GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317156-A1 NEW POLYMER LINKED MULTIMERS OF GUANOSINE-3', 5'-CYCLIC MONOPHOSPHATES PRKG1, PRKG2, PDE7A ADORA3 449/4885ADORA1 828/4885TP53 3284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.